Zurich Cantonal Bank’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-1,164
| Closed | -$9.86K | – | 2659 |
|
2024
Q4 | $9.86K | Sell |
1,164
-247
| -18% | -$2.09K | ﹤0.01% | 2607 |
|
2024
Q3 | $16.3K | Sell |
1,411
-25
| -2% | -$289 | ﹤0.01% | 2604 |
|
2024
Q2 | $16.9K | Sell |
1,436
-64
| -4% | -$754 | ﹤0.01% | 2594 |
|
2024
Q1 | $17.8K | Buy |
+1,500
| New | +$17.8K | ﹤0.01% | 2633 |
|
2022
Q1 | – | Sell |
-3,085
| Closed | -$41K | – | 2782 |
|
2021
Q4 | $41K | Sell |
3,085
-313
| -9% | -$4.16K | ﹤0.01% | 2786 |
|
2021
Q3 | $59K | Buy |
3,398
+88
| +3% | +$1.53K | ﹤0.01% | 2568 |
|
2021
Q2 | $79K | Buy |
3,310
+138
| +4% | +$3.29K | ﹤0.01% | 2314 |
|
2021
Q1 | $81K | Buy |
+3,172
| New | +$81K | ﹤0.01% | 2236 |
|